MD Anderson Oncologist Stephen Hahn Is Trump’s First Choice For FDA Commissioner: Reports

Media reports say President Trump will nominate Stephen Hahn, an oncologist serving as chief medical executive of MD Anderson Cancer Center, as the next US FDA commissioner. This comes despite a group of former agency chiefs’ support for the current acting commissioner, Ned Sharpless, to permanently fill the spot.

Stephen Hahn, chief medical executive, MD Anderson Cancer Center.

Stephen Hahn, chief medical executive at MD Anderson Cancer Center, will be Trump’s pick to run the US Food and Drug Administration as long as he can complete the necessary FBI background checks and other vetting processes, media reports say.

A radiation oncologist at the cancer center – part of the University of Texas system in Houston, TX – Hahn is an active clinician specializing in treatment of thoracic and...

More from Leadership

More from Medtech Insight